PENNVAX
Live / Registered — Registered (as of 24 Sept 2019)
What this means for you
Registered since 24 Sept 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88080254
- Registration number
- 5865728
- Mark type
- Stylized text
- Filed
- 15 Aug 2018
- Published for opposition
- 09 Jul 2019
- Registered
- 24 Sept 2019
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions for the prevention and treatment of acquired immunodeficiency syndrome, cancer and infectious diseases; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of acquired immunodeficiency syndrome (AIDS)
Owner
- Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US
- Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US
- Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, US
Prosecution history
- 24 Sept 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Sept 2019 — REGISTERED-PRINCIPAL REGISTER
- 09 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2019 — PUBLISHED FOR OPPOSITION
- 19 Jun 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 May 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 May 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 May 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 May 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Dec 2018 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 07 Dec 2018 — PRIORITY ACTION E-MAILED
- 07 Dec 2018 — PRIORITY ACTION WRITTEN
- 30 Nov 2018 — ASSIGNED TO EXAMINER
- 17 Oct 2018 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 17 Oct 2018 — ASSIGNED TO LIE